What does Macquarie think Liontown Resources shares are worth?

Is the broker bullish or bearish or something in between? Let's find out.

| More on:
Lion holding and screaming into a yellow loudspeaker on a blue background, symbolising an announcement from Liontown.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Liontown Resources Ltd (ASX: LTR) shares are starting the week deep in the red.

In afternoon trade, the lithium miner's shares are down 5% to 67 cents.

This means that they have now lost a third of their value since this time last year.

Is this a buying opportunity for investors? Let's see what analysts at Macquarie Group Ltd (ASX: MQG) are saying about the owner and operator of the Kathleen Valley Lithium Project.

Are Liontown shares good value?

Firstly, the broker has been looking at lithium prices and unfortunately notes that they remain subdued. It said:

The lithium market remains subdued with key prices down YTD. China Spodumene Li2O 6% and Asia lithium hydroxide fell 23% and 8%, respectively. China lithium carbonate and hydroxide dropped 19% and 13%.

The bad news is that despite this, lithium supply continues to grow, which is making it hard for lithium prices to stage any sort of recovery. The broker adds:

Lithium supply not slowing down: While multiple lithium refineries in China are undergoing planned maintenance, lepidolite production and spodumene imports remain robust.

But it doesn't believe things will stay this way forever, which is how the market is valuing lithium shares like Pilbara Minerals Ltd (ASX: PLS) and Liontown. Macquarie highlights:

Miners are trading with implied lithium price close to US$1,000/t (LT, perpetuity). PLS has the lowest implied spodumene price at US$925/t while LTR is trading with the highest implied lithium price at US$1,225/t. Both IGO and SYA are trading at ~US$1,000/t implied spodumene price (SC6%).

While the broker expects lithium prices to remain subdued in FY 2026, it is forecasting a recovery in 2027 through to 2030. In fact, by the end of the decade, Macquarie expects the spodumene 6% price to be up at US$1,750 per tonne.

In light of this, it thinks the market is undervaluing Pilbara Minerals shares and has an outperform rating and $2.40 price target on its shares.

For Liontown Resources shares, the broker is sitting on the fence with a neutral rating and 65 cents price target. This is largely in line with where its shares trade today. It adds:

Funding assumptions to develop both the Kathleen Valley Spodumene and Lithium Hydroxide projects are the key risks to our base case. Movements in spodumene and lithium prices that vary compared to our forecasts present risks (both upside and downside) to our earnings estimates and valuation for LTR. Geotechnical management of mining hard-rock pegmatites underground, variations in our capital and operating cost assumptions as well as the ramp-up profile of both the open pit and underground mines also present risks for LTR.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Market News

Why Aeris Resources, Netwealth, Nova Minerals, and Paragon Care shares are dropping today

These shares are under pressure on Friday. Let's find out why.

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Share Market News

Downer EDI wins $870m NZ highway maintenance contracts: What investors need to know

Downer EDI wins major New Zealand state highway maintenance contracts worth NZ$870 million, expanding its infrastructure portfolio.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Broker Notes

Ord Minnett names 2 ASX 200 shares to buy for massive returns

The broker sees a lot of value in these big names. Here's what it is recommending.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »